Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 321-326

  Acciuffi, S ^a   Ghosh, S ^a   Ferguson, A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST; DISEASE ACTIVITY; ENTERITIS; ENTEROPATHY; HUMAN; ILEOSTOMY; INTESTINE LAVAGE; PRIORITY JOURNAL; PROTEIN DEPLETION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DIGESTIVE SYSTEM; HUMANS; ILEOSTOMY; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; IRRIGATION; PROTEIN-LOSING ENTEROPATHIES; REFERENCE VALUES;

EID: 0029955649     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00321.x     Document Type: Article

References (20)

1. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
2. Hodgson HJF, Bhatti M. Clinical trials and therapeutics. Assessment of disease activity in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1995; 1: 117-34.
3. De Dombal FT, Softley A. Special Report. IOIBD report No. 1: observer variation in calculating indices of severity and activity in Crohn's disease. Gut 1987; 28: 474-81.
4. Cellier C, Sahmoud T, Froguel E, et al. and Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Correlations between clinical activity, endoscopic severity, and biological parameters in colonie or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. Gut 1994; 35: 231-5.
5. 111In in granulocyte excretion. Digestion 1986; 33: 74-9.
6. Crama-Bohbouth G, Pena AS, Biemond I, et al. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease. Gut 1989; 30: 1236-40.
7. Modigliani R, Mary J-Y, Simon J-F, et al. and Groupe D'Etude Thérapeutique des Affections Inflammatoires Digestives. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on Prednisolone. Gastroenterology 1990; 98: 811-8.
8. 111In-labeled granulocytes. Digestion 1991; 50: 149-52.
9. Logan RFA, Gillon J, Ferrington C, Ferguson A. Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut 1981; 22: 383-7.
10. Van Hees PAM, Van Elteran PH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21: 279-86.
11. Kaufman S, Chalmer B, Heilman R, Beeken W. A prospective study of the course of Crohn's disease. Dig Dis Sci 1979; 24: 269-76.
12. 3) proteins in patients with Crohn's disease. Scand J Gastroenterol 1990; 25: 345-51.
13. Ferguson A, Sallam J, O'Mahony S, Poxton I. Clinical investigation of gut immune responses. Review on non-parenteral vaccines. Advanced Drug Delivery 1995; 18: 53-71.
14. Ferguson A, Ghosh S, Brydon WG. Use of whole gut lavage fluid to measure occult GI bleeding and protein-losing enteropathy. Z Gastroenterol (in press).
15. Brydon WG, Choudari CP, Ferguson A. Relative specificity for active inflammatory bowel disease of plasma-derived proteins in gut lavage fluid. Eur J Gastroenterol Hepatol 1993; 5: 269-73.
16. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13: 833-7.
17. Choudari CP, O'Mahony S, Brydon G, Mwantembe O, Ferguson A. Concentrations of immunoglobulin G, albumin and alpha-1-antitrypsin in whole gut lavage fluid: objective measures of disease activity in inflammatory bowel disease. Gastroenterology 1993; 104: 1064-71.
18. O'Mahony S, Barton JR, Crichton S, Ferguson A. Appraisal of gut lavage in the study of intestinal humoral immunity. Gut 1990; 31: 1341-4.
19. Ferguson A. Inflammatory bowel disease in children and adolescents. Hospital Update 1992; 18: 721-32.
20. Ferguson A, Ghosh S, Handy LM, et al. Analysis of disease distribution, activity and complications in the patient with inflammatory bowel disease. Scand J Gastroenterol 1994; 29 (Suppl. 203): 15-9.